2024
AbbVie Golden Ticket
Apply by October 27, 2024
AbbVie and BioLabs Europe invite you to apply for up to two Golden Tickets. The Golden Ticket provides a lab bench and office space, and a membership for one year, and access to the AbbVie team of scientific and industry advisors.
Golden Ticket Benefits
Application requirements
AbbVie is looking for early-stage biotech companies that fit the following criteria:
Focused on science / technology with potential to generate transformational therapies in areas that align strategically with AbbVie’s therapeutic areas of interest (listed below and available here)
Developing therapeutic platform technologies, including gene therapy, novel drug-discovery or platform technologies
Exclusions: Diagnostics, Devices, Research Tools, and Healthcare Services/IT
Therapeutic Areas at a Glance
Additional Requirements
-
Companies must have their principal place of business in the Heidelberg or Paris area or be willing to relocate to one of the locations
-
Companies must not have a significant partnership with another large biopharmaceutical company
-
However, current, or prior recipients of similar awards sponsored by other pharmaceutical companies or lab spaces are eligible to apply
-
-
Companies must meet Biolabs' Golden Ticket criteria:
-
Total equity funding raised must be less than $7.5M USD before the Golden Ticket is issued to them
-
Companies must not have trailing 12-month revenues in excess of $3M USD
-
Companies must be in the life sciences and have an impact on human health
-
Companies must be financially and scientifically ready to move into Biolabs Heidelberg or Paris within three months of receiving the ticket
-
The Application Process
01
Submit applications by
October 27, 2024
02
A subset of applications will be identified as finalist by the contest judges by
November 1, 2024
03
Finalists will present their company & scientific concept at a virtual event
on November 13 or 14, 2024
04
Up to 2 awards will be granted
Good luck!
Judging Criteria and Judges
AbbVie leaders who are qualified scientific experts in their respective fields, including specialties in scientific and/or medical research and business, will review all submissions. The following criteria will form application judging criteria:
Fit relating to the research fields of oncology, immunology, neuroscience, eye care, or aesthetics. Judges will also consider novel target(s) identification, drug delivery, discovery technology platforms, and translational research and development.
Quality of the scientific data, research plan and/or technology platform
Potential to successfully achieve research milestones and program development
Unmet need for the research in the relevant field. Is this research/program/technology addressing a critical medical need
Readiness to move into the Biolabs Heidelberg or Paris lab space within three months of being selected for the award
Contact Us
